Eva M. Muchitsch

614 total citations
23 papers, 466 citations indexed

About

Eva M. Muchitsch is a scholar working on Hematology, Immunology and Genetics. According to data from OpenAlex, Eva M. Muchitsch has authored 23 papers receiving a total of 466 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Hematology, 7 papers in Immunology and 6 papers in Genetics. Recurrent topics in Eva M. Muchitsch's work include Hemophilia Treatment and Research (10 papers), Platelet Disorders and Treatments (6 papers) and Coagulation, Bradykinin, Polyphosphates, and Angioedema (4 papers). Eva M. Muchitsch is often cited by papers focused on Hemophilia Treatment and Research (10 papers), Platelet Disorders and Treatments (6 papers) and Coagulation, Bradykinin, Polyphosphates, and Angioedema (4 papers). Eva M. Muchitsch collaborates with scholars based in Austria, United States and Italy. Eva M. Muchitsch's co-authors include Alexandra Schiviz, Peter L. Turecek, Birgit M. Reipert, Rafi U. Ahmad, Hans Peter Schwarz, Christina Hausl, Teshell K. Greene, Mortimer Poncz, H. P. Schwarz and Friedrich Dorner and has published in prestigious journals such as Blood, Journal of Allergy and Clinical Immunology and Journal of Thrombosis and Haemostasis.

In The Last Decade

Eva M. Muchitsch

22 papers receiving 452 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Eva M. Muchitsch Austria 13 298 127 101 81 58 23 466
Margaret F. Veale Australia 15 288 1.0× 58 0.5× 96 1.0× 93 1.1× 21 0.4× 20 628
Carine Prisco Arnoni Brazil 10 110 0.4× 68 0.5× 82 0.8× 37 0.5× 11 0.2× 42 354
Nobuhiko Ikari Japan 10 61 0.2× 91 0.7× 85 0.8× 65 0.8× 23 0.4× 17 353
Signy Chow Canada 9 111 0.4× 38 0.3× 202 2.0× 22 0.3× 40 0.7× 21 442
Noémi Roy United Kingdom 12 147 0.5× 131 1.0× 119 1.2× 85 1.0× 6 0.1× 26 419
RA Johnson United States 4 142 0.5× 67 0.5× 124 1.2× 38 0.5× 9 0.2× 5 354
Rita Gottschalk United States 15 141 0.5× 29 0.2× 145 1.4× 228 2.8× 15 0.3× 30 562
M. Palm Sweden 9 178 0.6× 37 0.3× 70 0.7× 34 0.4× 11 0.2× 13 408
Giuseppe Dell’Elba Italy 11 150 0.5× 21 0.2× 102 1.0× 160 2.0× 10 0.2× 18 483

Countries citing papers authored by Eva M. Muchitsch

Since Specialization
Citations

This map shows the geographic impact of Eva M. Muchitsch's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eva M. Muchitsch with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eva M. Muchitsch more than expected).

Fields of papers citing papers by Eva M. Muchitsch

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Eva M. Muchitsch. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eva M. Muchitsch. The network helps show where Eva M. Muchitsch may publish in the future.

Co-authorship network of co-authors of Eva M. Muchitsch

This figure shows the co-authorship network connecting the top 25 collaborators of Eva M. Muchitsch. A scholar is included among the top collaborators of Eva M. Muchitsch based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Eva M. Muchitsch. Eva M. Muchitsch is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Piskernik, Christina, Barbara Plaimauer, Frank Horling, et al.. (2016). Preclinical assessment of a new recombinant ADAMTS‐13 drug product (BAX930) for the treatment of thrombotic thrombocytopenic purpura. Journal of Thrombosis and Haemostasis. 14(7). 1410–1419. 21 indexed citations
2.
Schiviz, Alexandra, et al.. (2014). Influence of genetic background on bleeding phenotype in the tail‐tip bleeding model and recommendations for standardization: communication from the SSC of the ISTH. Journal of Thrombosis and Haemostasis. 12(11). 1940–1942. 9 indexed citations
3.
Helden, Pauline M. van, Corinna Hermann, Maria Schuster, et al.. (2011). Maintenance and break of immune tolerance against human factor VIII in a new transgenic hemophilic mouse model. Blood. 118(13). 3698–3707. 22 indexed citations
4.
Greene, Teshell K., et al.. (2010). Towards a standardization of the murine tail bleeding model. Journal of Thrombosis and Haemostasis. 8(12). 2820–2822. 70 indexed citations
5.
Reipert, Birgit M., Peter Allacher, Christina Hausl, et al.. (2010). Modulation of factor VIII‐specific memory B cells. Haemophilia. 16(102). 25–34. 19 indexed citations
6.
Weber, Alfred, Wolfgang Teschner, Eva M. Muchitsch, et al.. (2010). Biochemical, molecular and preclinical characterization of a double‐virus‐reduced human butyrylcholinesterase preparation designed for clinical use. Vox Sanguinis. 100(3). 285–297. 27 indexed citations
7.
Bennani‐Baïti, Barbara, et al.. (2010). Serum-derived immunoglobulins alter amyloid beta transport across a blood-brain barrier in vitro model.. PubMed. 65(4). 267–73. 7 indexed citations
8.
Teschner, Wolfgang, et al.. (2010). Effects of Recombinant Human Hyaluronidase (rHuPH20) on Subcutaneous Administration of 10% and 20% IgG in Yucatan Mini Pigs. Journal of Allergy and Clinical Immunology. 125(2). AB139–AB139. 1 indexed citations
9.
Baumgartner, Bridget, Thomas Jaki, Martin J. Wolfsegger, et al.. (2010). Optimization, refinement and reduction of murine in vivo experiments to assess therapeutic approaches for haemophilia A. Laboratory Animals. 44(3). 211–217. 10 indexed citations
10.
Váradi, Katalin, Hanspeter Rottensteiner, Susanne Vejda, et al.. (2009). Species‐dependent variability of ADAMTS13‐mediated proteolysis of human recombinant von Willebrand factor. Journal of Thrombosis and Haemostasis. 7(7). 1134–1142. 16 indexed citations
11.
Hausl, Christina, Peter Allacher, Rafi U. Ahmad, et al.. (2008). Requirements for Co-Stimulation in T-Cell Dependent and T-Cell Independent Re-Stimulation of FVIII-Specific Memory B Cells. Blood. 112(11). 238–238. 18 indexed citations
12.
Helden, Pauline M. van, Maria Schuster, Gerhard Antoine, et al.. (2008). Immune Tolerance to Human Factor VIII Induced by Liver-Specific Expression of a Human Factor VIII Transgene in Hemophilic Mice.. Blood. 112(11). 3387–3387. 1 indexed citations
13.
Emeis, J.J., et al.. (2007). A guide to murine coagulation factor structure, function, assays, and genetic alterations. Journal of Thrombosis and Haemostasis. 5(4). 670–679. 33 indexed citations
14.
Maier, Elisabeth, Birgit M. Reipert, Bernhard Baumgartner, et al.. (2006). Induction of immune tolerance by oral IVIG. International Immunopharmacology. 7(3). 351–359. 5 indexed citations
15.
Franceschi, Lucia De, Giorgio Malpeli, Aldo Scarpa, et al.. (2006). Protective effects ofS-nitrosoalbumin on lung injury induced by hypoxia-reoxygenation in mouse model of sickle cell disease. American Journal of Physiology-Lung Cellular and Molecular Physiology. 291(3). L457–L465. 25 indexed citations
16.
Teschner, Wolfgang, Wilfried Auer, Eva M. Muchitsch, et al.. (2006). A new liquid, intravenous immunoglobulin product (IGIV 10%) highly purified by a state‐of‐the‐art process. Vox Sanguinis. 92(1). 42–55. 27 indexed citations
17.
Franceschi, Lucia De, Filomena Daraio, Sonia Carturan, et al.. (2006). Liver expression of hepcidin and other iron genes in two mouse models of beta-thalassemia.. PubMed. 91(10). 1336–42. 51 indexed citations
18.
Hausl, Christina, Rafi U. Ahmad, Hans Peter Schwarz, et al.. (2004). Preventing restimulation of memory B cells in hemophilia A: a potential new strategy for the treatment of antibody-dependent immune disorders. Blood. 104(1). 115–122. 70 indexed citations
19.
Pichler, Ludwig, Eva M. Muchitsch, & H. P. Schwarz. (1999). [Preclinical investigation of alpha 1-acid glycoprotein (orosomucoid)].. PubMed. 111(5). 192–8. 6 indexed citations
20.
Auer, Wilfried, et al.. (1997). Studies on the effect of human lys-plasminogen in a rat model of global cerebral ischemia.. PubMed. 47(11). 1195–9. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Margaret F. Veale Breakdown of academic impact, for papers by Carine Prisco Arnoni Breakdown of academic impact, for papers by Nobuhiko Ikari Breakdown of academic impact, for papers by Signy Chow Breakdown of academic impact, for papers by Noémi Roy Breakdown of academic impact, for papers by RA Johnson Breakdown of academic impact, for papers by Rita Gottschalk Breakdown of academic impact, for papers by M. Palm Breakdown of academic impact, for papers by Giuseppe Dell’Elba
Rankless by CCL
2026